Core Insights - Rigel Pharmaceuticals, Inc. is a biotechnology company focused on hematologic disorders and cancer, and it will present an overview at the Piper Sandler 37th Annual Healthcare Conference on December 3, 2025 [1][3]. Company Overview - Rigel Pharmaceuticals was founded in 1996 and is based in South San Francisco, California [3]. - The company is dedicated to discovering, developing, and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer [3]. Event Details - Dean Schorno, the Chief Financial Officer of Rigel, will present at the conference at 8:30 am ET [1]. - Investors can access the live webcast or archived recording through the Investor Relations section of Rigel's website [2].
Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference